The downgrade reflects Moody’s expectation that Baxter will maintain margins at a lower level, and liquidity will grow slowly.
The rating outlook has been revised from negative to stable.
More articles on healthcare finance:
How CHS, Tenet, HCA and UHS fared in Q4
Temple University Health System’s operating loss narrows to $26.2M
Oklahoma hospital operator ousted over ‘immediate threat’ to patient safety
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit